Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by Abpatchkid1on Aug 11, 2016 7:09pm
123 Views
Post# 25133410

Latest News

Latest News

Aurora Cannabis Inc. (CNSX:ACB) now has more than 6,500 active registered patients, just seven months after the company sold its first product.

That’s believed to be the fastest rate of patient registration after commencement of commercial operations achieved by any Licensed Producer in Canada, the company explained.

The company also hit $1mln in gross revenue in July, with 24% sales growth month-over-month.

"The Aurora Standard continues to deliver," said Aurora CEO Terry Booth. "To grow to over 6,500 registered patients in seven months is unheard of, and has only been possible due to consistent execution on our production, commercial and customer experience strategies."

Aurora’s sales of dried cannabis showed strong growth, the company explained. The total weight of product sold in July reached 124,000 grams, versus 100,000 grams in the previous month.

Aurora provides same-day delivery of medical cannabis to clients in Calgary and the surrounding area. They operate a 55,200 square foot production facility in Mountain View County, Alberta. The company is also bottling cannabis oil and storing cannabis concentrate, getting ready to son roll out a line of ingestible cannabis oils.

Aurora shares were flat at C$0.67 after mid-session on Thursday.

Bullboard Posts